Identifying and Quantifying Mutagenic Impurities in Pharmaceutical Products
Article
LCGC E-Books
LCGC E-BooksLCGC E-Books-07-20-2020
Issue 17
Pages: 17–26
Meeting detection challenges presented by nitrosamine impurities
Determination of NDMA and nitrosamine impurities using triple-quadrupole LC/MS
Determination of genotoxic impurities in ranitidine APIs and drug products